secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001193125-24-042903
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics VP Finance resigns; Ferdinand Groenewald appointed as replacement via consulting agreement
--------------------------------------------------------------------------------

- Michael Wong resigned as VP Finance effective Feb 23, 2024.
- Ferdinand Groenewald appointed as VP Finance effective Feb 22, 2024 via consulting agreement.
- Consulting agreement pays $15,000 per month; indefinite term with 30-day termination notice.
- Groenewald previously served as CFO and CAO of Muscle Maker, Inc.; is a CPA.
- Agreement includes customary indemnification and business expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312524042903/0001193125-24-042903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312524042903/d929353d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-042903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer